Abstract
We read with interest the work of Kolloch et al. 1 about the relationship between resting heart rate (RHR) and adverse events in patients with hypertension and coronary artery disease from the population of the INternational VErapamil-SR/trandolapril STudy (INVEST study). This study reported that higher baseline and follow-up RHR were associated with increased adverse outcome risks. Taking into account that this study showed that, despite the atenolol-based strategy …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
